Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery

Transfusion

Volumn 53, Issue 4, 2013, Pages 920-921

  Tanaka, Kenichi A ^a   Mazzeffi, Michael A ^b   Grube, Matthias ^b   Ogawa, Satoru ^b   Chen, Edward P ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9 COMPLEX; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; CRYOPRECIPITATE; DRUG COST; DRUG FATALITY; ERYTHROCYTE; HEMATOCRIT; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; LETTER; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOSIS; VENTRICULAR ASSIST DEVICE;

ADULT; AGED; BLOOD COAGULATION FACTORS; CARDIAC SURGICAL PROCEDURES; FACTOR VIIA; FEMALE; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84876146115     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12110     Document Type: Letter

References (5)

1. Weber CF, Gorlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K,. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-547.
2. Gill R, Herbertson M, Vuylsteke A, Olsen PS, von, Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA,. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009; 120: 21-27.
3. Sniecinski RM, Chen EP, Makadia SS, Kikura M, Bolliger D, Tanaka KA,. Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest. J Cardiothorac Vasc Anesth 2010; 24: 959-963.
4. Ogawa S, Szlam F, Ohnishi T, Molinaro RJ, Hosokawa K, Tanaka KA,. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. Thromb Haemost 2011; 106: 1215-1223.
5. Mitterlechner T, Innerhofer P, Streif W, Lodl M, Danninger T, Klima G, Hansson K, Fries D,. Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model. J Thromb Haemost 2011; 9: 729-737.